Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication in Nava Telangana (Telugu) and Business Standard.13-01-2024
13-01-2024
Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot12-01-2024
Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate Under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31, 202303-01-2024
Suven Pharmaceuticals Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund28-12-2023
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Resignation of Mr. Subba Rao Parupalli as Chief Financial Officer of the Company22-12-2023
Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
The Board has approved the amendment to Code of internal procedures and conduct for regulating, monitoring and reporting of trading by Insiders, code of practices and procedures for fair diclosure of Unpublished Price Sesitive Information and Policy on Determination of Ligitimate puupose, in pursuance of the SEBI(PIT) Regulations, 2015.21-12-2023
Suven Pharmaceuticals Ltd - 543064 - Appointment Of Mr Himanshu Agarwal As Chief Financial Officer And Key Managerial Personnel Of The Company W.E.F. January 02, 2024
Pursunat to the recommendations of NRC and approval of Audit Committee, the Board has considered and approved the appointment of Mr. Himanshu Agarwal as the Chief Financial Officer and Key Managerial Personnel of the Company w.e.f January 2, 2024 in place of Mr. Subba Rao Parupalli21-12-2023
Suven Pharmaceuticals Ltd - 543064 - Board Meeting Outcome for Outcome Of The Board Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations"), we wish to inform that the Board of Directors of the Company, at its meeting held today i.e., December 21, 2023, inter alia, approved the following along with other business matters21-12-2023
Suven Pharmaceuticals Ltd - 543064 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 5th Annual General Meeting held on December 15, 2023, Voting results and Report of Scrutinizer.15-12-2023